Report Detail
Global (United States, European Union and China) HGH Biosimilars Market Research Report 2019-2025
- RnM3672404 |
- 16 August, 2019 |
- Global |
- 118 Pages |
- QYResearch |
- Pharma & Healthcare
HGH Biosimilars is DNA recombinant human growth hormone, which has the same function as human growth hormone. It can promote bone, visceral and whole body growth, promote protein synthesis, affect fat and mineral metabolism, and play a key role in human growth and development. Subcutaneous injection of about 80% was absorbed, 5 hours to reach the peak of blood drug concentration, the half-life of 4 hours. About 90% of the injection dose is metabolized in the liver. Only about 0.1% of the dose is excreted from the biliary tract and the kidneys.
The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World. Annual estimates and forecasts are provided for the period 2018 through 2025. Also, a five-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research.
This report analyzes the worldwide markets for HGH Biosimilars in US$ by following Product Segments.: Clinical, Experiment and Others
Company profiles are primarily based on public domain information including company
Johnson & Johnson
Gilead Sciences
Pacira
Sun Pharmaceutical
Luye Pharma
Sigma-Tau Group
Fudan-Zhangjiang
Teva Pharmaceutical
CSPC
Novartis
Kingond Pharm
In 2019, the market size of HGH Biosimilars is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for HGH Biosimilars.
This report studies the global market size of HGH Biosimilars, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the HGH Biosimilars sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
In global market, the following companies are covered:
Johnson & Johnson
Gilead Sciences
Pacira
Sun Pharmaceutical
Luye Pharma
Sigma-Tau Group
Fudan-Zhangjiang
Teva Pharmaceutical
CSPC
Novartis
Kingond Pharm
Market Segment by Product Type
Clinical
Experiment
Market Segment by Application
Treament
Prevention
Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
The study objectives are:
To analyze and research the HGH Biosimilars status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key HGH Biosimilars manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
In this study, the years considered to estimate the market size of HGH Biosimilars are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
Table of Contents
1 Report Overview
- 1.1 Study Scope
- 1.2 Major Manufacturers Covered in This Report
- 1.3 Market Segment by Type
- 1.3.1 Global HGH Biosimilars Market Size Growth Rate by Type (2019-2025)
- 1.3.2 Clinical
- 1.3.3 Experiment
- 1.4 Market Segment by Application
- 1.4.1 Global HGH Biosimilars Market Share by Application (2019-2025)
- 1.4.2 Treament
- 1.4.3 Prevention
- 1.5 Study Objectives
- 1.6 Years Considered
2 Global Growth Trends
- 2.1 Global HGH Biosimilars Market Size
- 2.1.1 Global HGH Biosimilars Revenue 2014-2025
- 2.1.2 Global HGH Biosimilars Sales 2014-2025
- 2.2 HGH Biosimilars Growth Rate by Regions
- 2.2.1 Global HGH Biosimilars Sales by Regions 2014-2019
- 2.2.2 Global HGH Biosimilars Revenue by Regions 2014-2019
- 2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
3 Market Share by Manufacturers
- 3.1 HGH Biosimilars Sales by Manufacturers
- 3.1.1 HGH Biosimilars Sales by Manufacturers 2014-2019
- 3.1.2 HGH Biosimilars Sales Market Share by Manufacturers 2014-2019
- 3.2 Revenue by Manufacturers
- 3.2.1 HGH Biosimilars Revenue by Manufacturers (2014-2019)
- 3.2.2 HGH Biosimilars Revenue Share by Manufacturers (2014-2019)
- 3.2.3 Global HGH Biosimilars Market Concentration Ratio (CR5 and HHI)
- 3.3 HGH Biosimilars Price by Manufacturers
- 3.4 Key Manufacturers HGH Biosimilars Plants/Factories Distribution and Area Served
- 3.5 Date of Key Manufacturers Enter into HGH Biosimilars Market
- 3.6 Key Manufacturers HGH Biosimilars Product Offered
- 3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
- 4.1 Sales and Revenue for Each Type
- 4.1.1 Clinical Sales and Revenue (2014-2019)
- 4.1.2 Experiment Sales and Revenue (2014-2019)
- 4.2 Global HGH Biosimilars Sales Market Share by Type
- 4.3 Global HGH Biosimilars Revenue Market Share by Type
- 4.4 HGH Biosimilars Price by Type
5 Market Size by Application
- 5.1 Overview
- 5.2 Global HGH Biosimilars Sales by Application
6 United States
- 6.1 United States HGH Biosimilars Breakdown Data by Company
- 6.2 United States HGH Biosimilars Breakdown Data by Type
- 6.3 United States HGH Biosimilars Breakdown Data by Application
7 European Union
- 7.1 European Union HGH Biosimilars Breakdown Data by Company
- 7.2 European Union HGH Biosimilars Breakdown Data by Type
- 7.3 European Union HGH Biosimilars Breakdown Data by Application
8 China
- 8.1 China HGH Biosimilars Breakdown Data by Company
- 8.2 China HGH Biosimilars Breakdown Data by Type
- 8.3 China HGH Biosimilars Breakdown Data by Application
9 Rest of World
- 9.1 Rest of World HGH Biosimilars Breakdown Data by Company
- 9.2 Rest of World HGH Biosimilars Breakdown Data by Type
- 9.3 Rest of World HGH Biosimilars Breakdown Data by Application
- 9.4 Rest of World HGH Biosimilars Breakdown Data by Countries
- 9.4.1 Rest of World HGH Biosimilars Sales by Countries
- 9.4.2 Rest of World HGH Biosimilars Revenue by Countries
- 9.4.3 Japan
- 9.4.4 Korea
- 9.4.5 India
- 9.4.6 Southeast Asia
10 Company Profiles
- 10.1 Johnson & Johnson
- 10.1.1 Johnson & Johnson Company Details
- 10.1.2 Company Description and Business Overview
- 10.1.3 Sales, Revenue and Market Share of HGH Biosimilars
- 10.1.4 HGH Biosimilars Product Introduction
- 10.1.5 Johnson & Johnson Recent Development
- 10.2 Gilead Sciences
- 10.2.1 Gilead Sciences Company Details
- 10.2.2 Company Description and Business Overview
- 10.2.3 Sales, Revenue and Market Share of HGH Biosimilars
- 10.2.4 HGH Biosimilars Product Introduction
- 10.2.5 Gilead Sciences Recent Development
- 10.3 Pacira
- 10.3.1 Pacira Company Details
- 10.3.2 Company Description and Business Overview
- 10.3.3 Sales, Revenue and Market Share of HGH Biosimilars
- 10.3.4 HGH Biosimilars Product Introduction
- 10.3.5 Pacira Recent Development
- 10.4 Sun Pharmaceutical
- 10.4.1 Sun Pharmaceutical Company Details
- 10.4.2 Company Description and Business Overview
- 10.4.3 Sales, Revenue and Market Share of HGH Biosimilars
- 10.4.4 HGH Biosimilars Product Introduction
- 10.4.5 Sun Pharmaceutical Recent Development
- 10.5 Luye Pharma
- 10.5.1 Luye Pharma Company Details
- 10.5.2 Company Description and Business Overview
- 10.5.3 Sales, Revenue and Market Share of HGH Biosimilars
- 10.5.4 HGH Biosimilars Product Introduction
- 10.5.5 Luye Pharma Recent Development
- 10.6 Sigma-Tau Group
- 10.6.1 Sigma-Tau Group Company Details
- 10.6.2 Company Description and Business Overview
- 10.6.3 Sales, Revenue and Market Share of HGH Biosimilars
- 10.6.4 HGH Biosimilars Product Introduction
- 10.6.5 Sigma-Tau Group Recent Development
- 10.7 Fudan-Zhangjiang
- 10.7.1 Fudan-Zhangjiang Company Details
- 10.7.2 Company Description and Business Overview
- 10.7.3 Sales, Revenue and Market Share of HGH Biosimilars
- 10.7.4 HGH Biosimilars Product Introduction
- 10.7.5 Fudan-Zhangjiang Recent Development
- 10.8 Teva Pharmaceutical
- 10.8.1 Teva Pharmaceutical Company Details
- 10.8.2 Company Description and Business Overview
- 10.8.3 Sales, Revenue and Market Share of HGH Biosimilars
- 10.8.4 HGH Biosimilars Product Introduction
- 10.8.5 Teva Pharmaceutical Recent Development
- 10.9 CSPC
- 10.9.1 CSPC Company Details
- 10.9.2 Company Description and Business Overview
- 10.9.3 Sales, Revenue and Market Share of HGH Biosimilars
- 10.9.4 HGH Biosimilars Product Introduction
- 10.9.5 CSPC Recent Development
- 10.10 Novartis
- 10.10.1 Novartis Company Details
- 10.10.2 Company Description and Business Overview
- 10.10.3 Sales, Revenue and Market Share of HGH Biosimilars
- 10.10.4 HGH Biosimilars Product Introduction
- 10.10.5 Novartis Recent Development
- 10.11 Kingond Pharm
11 Value Chain and Sales Channels Analysis
- 11.1 Value Chain Analysis
- 11.2 Sales Channels Analysis
- 11.2.1 HGH Biosimilars Sales Channels
- 11.2.2 HGH Biosimilars Distributors
- 11.3 HGH Biosimilars Customers
12 Market Forecast
- 12.1 Global HGH Biosimilars Sales and Revenue Forecast 2019-2025
- 12.2 Global HGH Biosimilars Sales Forecast by Type
- 12.3 Global HGH Biosimilars Sales Forecast by Application
- 12.4 HGH Biosimilars Forecast by Regions
- 12.4.1 Global HGH Biosimilars Sales Forecast by Regions 2019-2025
- 12.4.2 Global HGH Biosimilars Revenue Forecast by Regions 2019-2025
- 12.5 United States Market Forecast
- 12.6 European Union Market Forecast
- 12.7 China Market Forecast
- 12.8 Rest of World
- 12.8.1 Japan
- 12.8.2 Korea
- 12.8.3 India
13 Research Findings and Conclusion
14 Appendix
- 14.1 Research Methodology
- 14.1.1 Methodology/Research Approach
- 14.1.1.1 Research Programs/Design
- 14.1.1.2 Market Size Estimation
- 14.1.1.3 Market Breakdown and Data Triangulation
- 14.1.2 Data Source
- 14.1.2.1 Secondary Sources
- 14.1.2.2 Primary Sources
- 14.1.1 Methodology/Research Approach
- 14.2 Author Details
Summary:
Get latest Market Research Reports on HGH Biosimilars. Industry analysis & Market Report on HGH Biosimilars is a syndicated market report, published as Global (United States, European Union and China) HGH Biosimilars Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of HGH Biosimilars market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
